Literature DB >> 18176997

Toward multivalent signaling across G protein-coupled receptors from poly(amidoamine) dendrimers.

Yoonkyung Kim1, Béatrice Hechler, Athena M Klutz, Christian Gachet, Kenneth A Jacobson.   

Abstract

Activation of the A2A receptor, a G protein-coupled receptor (GPCR), by extracellular adenosine, is antiaggregatory in platelets and anti-inflammatory. Multiple copies of an A2A agonist, the nucleoside CGS21680, were coupled covalently to PAMAM dendrimers and characterized spectroscopically. A fluorescent PAMAM-CGS21680 conjugate 5 inhibited aggregation of washed human platelets and was internalized. We envision that our multivalent dendrimer conjugates may improve overall pharmacological profiles compared to the monovalent GPCR ligands.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18176997     DOI: 10.1021/bc700327u

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  22 in total

1.  Multivalent dendrimeric and monomeric adenosine agonists attenuate cell death in HL-1 mouse cardiomyocytes expressing the A(3) receptor.

Authors:  Athena M Keene; Ramachandran Balasubramanian; John Lloyd; Asher Shainberg; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2010-03-25       Impact factor: 5.858

Review 2.  Introduction to adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson
Journal:  Handb Exp Pharmacol       Date:  2009

3.  Anti-ischemic effects of multivalent dendrimeric A₃ adenosine receptor agonists in cultured cardiomyocytes and in the isolated rat heart.

Authors:  Bella Chanyshev; Asher Shainberg; Ahuva Isak; Alexandra Litinsky; Yelena Chepurko; Dilip K Tosh; Khai Phan; Zhan-Guo Gao; Edith Hochhauser; Kenneth A Jacobson
Journal:  Pharmacol Res       Date:  2011-12-01       Impact factor: 7.658

4.  Functionalized congeners of P2Y1 receptor antagonists: 2-alkynyl (N)-methanocarba 2'-deoxyadenosine 3',5'-bisphosphate analogues and conjugation to a polyamidoamine (PAMAM) dendrimer carrier.

Authors:  Sonia de Castro; Hiroshi Maruoka; Kunlun Hong; S Michael Kilbey; Stefano Costanzi; Béatrice Hechler; Garth G Brown; Christian Gachet; T Kendall Harden; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2010-07-21       Impact factor: 4.774

5.  Nucleoside conjugates of quantum dots for characterization of G protein-coupled receptors: strategies for immobilizing A2A adenosine receptor agonists.

Authors:  Arijit Das; Gangadhar J Sanjayan; Miklós Kecskés; Lena Yoo; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  J Nanobiotechnology       Date:  2010-05-17       Impact factor: 10.435

6.  PEGylated dendritic unimolecular micelles as versatile carriers for ligands of G protein-coupled receptors.

Authors:  Yoonkyung Kim; Béatrice Hechler; Zhan-Guo Gao; Christian Gachet; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2009-09-28       Impact factor: 4.774

7.  Enhanced potency of nucleotide-dendrimer conjugates as agonists of the P2Y14 receptor: multivalent effect in G protein-coupled receptor recognition.

Authors:  Arijit Das; Yixing Zhou; Andrei A Ivanov; Rhonda L Carter; T Kendall Harden; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2009-07-02       Impact factor: 4.774

Review 8.  Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).

Authors:  Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2009-04-30       Impact factor: 4.774

9.  Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity.

Authors:  Yoonkyung Kim; Athena M Klutz; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2008-07-09       Impact factor: 4.774

10.  Application of the functionalized congener approach to dendrimer-based signaling agents acting through A(2A) adenosine receptors.

Authors:  Yoonkyung Kim; Athena M Klutz; Béatrice Hechler; Zhan-Guo Gao; Christian Gachet; Kenneth A Jacobson
Journal:  Purinergic Signal       Date:  2008-07-04       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.